Company Centogene N.V.

Equities

CNTG

NL0014040206

Biotechnology & Medical Research

Market Closed - Nasdaq 02:00:00 29/06/2024 am IST 5-day change 1st Jan Change
0.38 USD -2.64% Intraday chart for Centogene N.V. -1.81% -68.33%

Business Summary

Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.

Number of employees: 384

Sales per Business

USD in Million2022Weight2023Weight Delta
Diagnostics
69.5 %
33 66.1 % 36 69.5 % +10.66%
Pharmaceutical
30.5 %
17 33.9 % 16 30.5 % -5.51%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
30.6 %
17 34.8 % 16 30.6 % -7.55%
Saudi Arabia
27.6 %
13 26.2 % 14 27.6 % +10.69%
Europe
15.7 %
6 12.6 % 8 15.7 % +31.42%
Middle East
15.2 %
8 15.8 % 8 15.2 % +1.10%
Latin America
8.9 %
4 8.2 % 5 8.9 % +13.37%
Asia Pacific
1.8 %
1 1.7 % 1 1.8 % +16.22%
Germany
0.2 %
0 0.6 % 0 0.2 % -68.17%
North America
0.1 %
0 0.1 % 0 0.1 % -36.70%
Netherlands
0.0 %
0 0.0 % 0 0.0 % -70.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 20/21/20
Director of Finance/CFO - 08/22/08
Chief Tech/Sci/R&D Officer 54 01/16/01
Investor Relations Contact - -
Human Resources Officer - 01/12/01
Corporate Officer/Principal - 15/23/15

Members of the board

Members of the board TitleAgeSince
Chairman 57 16/20/16
Director/Board Member 57 01/17/01
Director/Board Member 68 01/17/01
Director/Board Member 46 01/19/01
Director/Board Member 52 10/20/10
Director/Board Member - 01/22/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,595,835 18,595,484 ( 67.39 %) 0 67.39 %

Shareholders

NameEquities%Valuation
DPE Deutsche Private Equity GmbH
26.69 %
7,739,658 26.69 % 3 M $
CareVentures SA
14.69 %
4,261,460 14.69 % 2 M $
TVM Capital GmbH
13.73 %
3,982,777 13.73 % 1 M $
Platinum Investment Management Ltd.
8.195 %
2,376,442 8.195 % 881 660 $
Platinum Investment Management Ltd.
4.090 %
1,186,102 4.090 % 440 044 $
Scoggin Management LP
1.833 %
531,571 1.833 % 197 213 $
ACATIS Investment Kapitalverwaltungsgesellschaft mbH
1.223 %
354,745 1.223 % 131 610 $
350,145 1.207 % 129 904 $
348,322 1.201 % 129 227 $
300,000 1.034 % 111 300 $

Company contact information

Centogene NV

Am Strande 7

18055, Rostock

+49 381 80113 500

http://www.centogene.com
address Centogene N.V.(CNTG)
  1. Stock Market
  2. Equities
  3. CNTG Stock
  4. Company Centogene N.V.